FEES
PARTICIPANT FEE $90 (Due at pre-registration. Our policy does not allow for cancellations or refunds)
Continuing education for this event is sponsored by The Institute for Continuing Education. The program offers 5.00 contact hours, with full attendance required. CE applications will be available on site. There is no fee to receive CE credit. CE credit is offered for: psychology ( APA); counseling ( NBCC provider 5643); social work ( ACSW provider 1007); drug-alcohol ( NAADAC provider 00243); MFT: This program has not been pre-approved for MA / RI MFTs.
For questions regarding continuing education, contact The Institute at: instconted@aol.com
ADA: If you have special needs or any questions please contact Regina King at 978-417-1780 or regs5@prakashellenhorn.com
Dr.Ross Ellenhorn Trained as a social worker, sociologist and psychotherapist, Dr. Ellenhorn has spent the last two decades dedicated to the work of helping individuals suffering psychiatric symptoms find the psychological and social means for remaining outside the hospital. Along with his partner, Dr. Madhavi Prakash, he created Prakash Ellenhorn, an intensive, and holistic outreach program, serving clients in the Boston area.
Patient Careerism and Parasuicidality: A Psychosocial Look at repeated suicidal gestures
At the conclusion of this interactive workshop, participants should be able to:
Dr.Raymond Kotwicki As chief medical officer, Ray Kotwicki oversees the organization’s clinical services, ensuring that the best, evidence-based treatments are being provided to patients. He joined Skyland Trail in 2007 and assumed full-time chief medical officer responsibilities in 2014. Message in a (PILL) Bottle:
Better understanding suicidal and parasuicidal behaviors At the conclusion of this interactive workshop, participants should be able to:
• Define terms suicidal and parasuicidal.
• List key motivations for both behaviors.
• Link parasuicidal behaviors to specific mental illnesses; review symptoms of mood disorders.
• Demonstrate an appreciation of the epidemiology of suicidal and parasuicidal behaviors in the US.
• Consider and describe modifiable and non-modifiable risk and protective factors in treatment planning for patients with these behaviors.
• Identify appropriate clinical and pharmacological interventions to respond to these behaviors.